Literature DB >> 15488677

Macromolecular prodrugs XI. Synthesis and characterization of polymer-estradiol conjugate.

M Zovko1, B Zorc, P Novak, P Tepes, B Cetina-Cizmek, M Horvat.   

Abstract

Estradiol-3-benzoate (EB), an ester derivative of the main oestrogen hormone estradiol, was chemically modified and bound to poly(alpha,beta-(N-2-hydroxyethyl-DL-aspartamide))-poly(alpha,beta-(N-2-aminoethyl-DL-aspartamide)) copolymer (PAHA). EB was first converted to estradiol-3-benzoate-17-(benzotriazole-1-carboxylate), which readily reacted with amino groups in PAHA affording the polymer-drug conjugate PAHA-EB. In PAHA-EB estradiol moiety was covalently bound to the polymeric carrier by carbamate linkage, through non-toxic ethylenediamine spacer. The synthesized compound is a potential hydrosoluble estradiol prodrug. copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15488677     DOI: 10.1016/j.ijpharm.2004.07.013

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs.

Authors:  Federica Sodano; Claudia Cristiano; Barbara Rolando; Elisabetta Marini; Loretta Lazzarato; Mariarosaria Cuozzo; Stefania Albrizio; Roberto Russo; Maria Grazia Rimoli
Journal:  Pharmaceuticals (Basel)       Date:  2022-04-29

Review 2.  The Prodrug Approach: A Successful Tool for Improving Drug Solubility.

Authors:  Daniela Hartmann Jornada; Guilherme Felipe dos Santos Fernandes; Diego Eidy Chiba; Thais Regina Ferreira de Melo; Jean Leandro dos Santos; Man Chin Chung
Journal:  Molecules       Date:  2015-12-29       Impact factor: 4.411

Review 3.  Prodrugs in cardiovascular therapy.

Authors:  Marinella G Sandros; Chady B Sarraf; Maryam Tabrizian
Journal:  Molecules       Date:  2008-05-14       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.